Medical Companies in Switzerland

Aligned (www.aligned.ch) provides Aligned Elements, an Application Lifecycle Management (ALM) software for Medical Device development. We assist our clients in developing, manufacture and market regulatory compliant products within shorter timeframes, to lower costs and with higher confidence. At Aligned, we believe that management of product and project documentation of regulatory compliant products shall be efficient and pragmatic. We advocate an apporach that allows your development team to focus on innovation instead of administration. Many of clients develop and manage medical products, regulated by norms such as the FDA QSR regulations in the USA or by the In Vitro Diagnostic Directives (IVD-D) in Europe. It is the special needs and circumstances which drive such projects that also shape our own portfolio. We strive to build value that last and therefore stay deeply involved with the undertakings of our clients until we are sure that sustainable results are achieved.

HAYA Therapeutics is a precision medicines company developing RNA-guided programmable therapeutics targeting the regulatory genome for serious health conditions including cardiovascular disease and cancer. The company is using its innovative cell-state modifying platform to gain novel insights into the biology of long non-coding RNAs (lncRNAs), the ‘dark genomes’ information processing features and ‘source code’. HAYA’s lead therapeutic candidate is HTX-001, an antisense oligonucleotide targeting Wisper, which is a tissue and cell-specific cardiac lncRNA known to play a role in heart failure. The company is also developing a pipeline of lncRNA-targeting candidates for the cell-specific treatment of diseases in other tissues, including the lungs and the microenvironment of solid tumor cancers. Headquartered at the life sciences park Biopôle in Lausanne, Switzerland with laboratory facilities at JLABS @ San Diego, HAYA is led by a world-class team of experts in programmable and precision RNA-targeted therapeutics and is supported by a strong investor consortium. HAYA’s mission is to identify and develop breakthrough disease-modifying therapeutics with the potential for greater efficacy, safety, and accessibility than existing treatments.

Heart Force is about to break new ground in the early detection of heart disease. Through the assessment of the cardiac performance with a new unique technology we are able to detect coronary artery diseases at an early stage. Our Cardiac Performance Metrics represent a new capability for analyzing cardiac timing, rhythm and strength not found in the personal monitoring and screening space. Cardiovascular disease (CVD) is the number one cause of death globally (Source: WHO). Early detection is the missing key to successfully combat CVD, but difficult to achieve; CVD often does not show any symptoms. Through Heart Force it will be possible to self monitor the overall heart health and spend a life with more clarity concerning the overall heart health.

Abionic, an in vitro diagnostics (IVD) company, was founded in 2010 as a spin-off from the Swiss Federal Institute of Technology of Lausanne (EPFL). Abionic is aiming to make a difference in patient care through the cutting-edge nanofluidic technology based ultra-rapid diagnostic platform, helping healthcare professionals to make clinical decisions at the point of care.

Aktiia – Bringing blood pressure monitoring to daily life Aktiia was founded in 2018 to commercialize its proprietary cuffless optical Blood Pressure Monitoring technology (oBPM™) in order to contribute to the prevention of high blood pressure, to save lives and to help reduce healthcare costs worldwide. aktiia is headquartered in Neuchatel (Switzerland) with offices opening up in Zurich (Switzerland) and the USA.

ALEVA is 👉THE COMPANY THAT INTRODUCED Directional Deep Brain Stimulation in Neuromodulation treatments and our clinically proven technology has set the industry standard for directional leads* Today we are 👉A SOLID COMPANY that following directSTIM™'s CE marking have started our commercial journey by partnering with the most important neurological clinics in Germany, with the goal to soon reach the most relevant European markets. We understand that if we want to help OUR CUSTOMERS, overcome their challenges, we need to 👉COMBINE SPECIALISATION with the 👉COMMITMENT TO BE RESPONSIVE to the everyday new challenges they experience. This is the attitude you will find in every ALEVA employee and sales representative who will be in contact with you. We are the 👉ONLY EUROPEAN COMPANY that designs, manufactures, and commercialises DBS devices for the treatment of Parkinson’s disease and essential tremor. Our production and R&D headquarters based in Switzerland complies to the highest quality standard for the highest safety of patients worldwide. Our A VISIONARY PROJECT SUSTAINED BY SOLID FOUNDATIONS: 👉a new group of investors that will sustain the completion of OUR PROJECT 👉a reinforced executive team who is complementing the existing successful group to partner with Neurosurgeons and Neurologists in the effective deployment of our Vision. *May 28, 2014 http://doi.org/10.1093/brain/awu102.

With Attolight, Cathodoluminescence (CL) is now available in a streamlined system which integrates CL with both light (LM) and electron microscopy (EM): what was a challenging experiment in the past, often done on klunky, home-made devices can now be done easily and efficiently. Attolight is now changing the landscape: its innovative approach brings nanometer resolution as well as pico-second timing for time-resolved studies, regardless of the wavelengths used. While any material that emits light under electron irradiation can be studied by CL, it is particularly valuable in material studies of semi-conductor materials, phosphor, ceramic, rock and glass. Combining LM, EM with hyperspectral imaging, Attolight’s solution reveals ultra-trace impurities and crystallographic defects not visible using other imaging modalities. Attolight "New Cathodoluminescence" solutions support the state-of-the -art research and developments in LEDs, Solar Cells, High Mobility Transitors, new opto-electronical devices, nano-structured semiconductors.

Our mission is to radically improve early detection of brain disorders. We combine Virtual Reality and Artificial Intelligence to empower ophthalmologists and neurologists with reliable measurements of eye and pupil movements. Our goal is to bring the diagnostic quality of highly trained tertiary care specialists where it is needed most, in primary and secondary care. 🏆 Ypsomed Innovation Award 2022 🏆 IMD Startup Competition 2022/23 🚀 Massachusettes Innovation Network, Global Eddies 2023

We brings precise microencapsulation at industrial scale: Microcaps developed a novel technology that enables the scalable production of precise microcapsules and microparticles based on microfluidics. With this invention, microcaps is able to increase the controlled production by a factor of 1000 compared to state-of-the-art technologies. Our goal is to provide an upscalable, fully-automated encapsulation micro-factory, that enables size control, precise dosing and increased stability of the microcapsules and microparticles.

Optimo Medical AG is a 100% privatly held med-tech company in eye care. We are dedicated to design and develop, produce and distribute software applications for planning, simulation, visualization, and training of therapy. Each day, more than 50'000 eyes are operated on around the globe and not two of them have the exact same characteristics. Each eye has an individual and unique shape and biomechanical behavior. At the same time, only fractions of a millimeter can determine if the surgery is a success, or irreparable harm is caused. Due to the very complex nature of the human cornea, restored vision for patient on one side, and medical and financial damage on the other, as an outcome, lie very close together. Hence, one of the major challenges for the eye surgeon: Guessing how an individual eye might react to the necessary cuts into the cornea. Optimeyes 1.0 replaces guessing by knowing. Our software simulates effects of physical interference planned for the individual eye, with a precision that outperforms conventional, non-personalized methods by far. This has now been solved in the Optimeyes™ software. Optimizing the incision parameters to the individual cornea by accounting for age, preoperative astigmatism, central-, and paracentral curvature, full pachymetry, and corneal biomechanical characteristics is now possible. The OptimeyesTM arcuate keratotomy planning and optimization module features two different operation modes: Prediction and Optimization. Prediction calculates the post-surgery cornea, based on given AK parameters. Optimization calculates the optimal surgery parameters for the individual patient. The Optimeyes team of Optimo Medical AG has many years of experience in corneal biomechanics, numerical simulation (FEM), and corneal topography. We are capable of providing senior level consulting services for surgeons, R&D engineers, and product managers. For more information: www.optimo-medical.com / www.optimeyes.ch

Sequana Medical NV is a pioneer in treating drug-resistant fluid overload, a serious and frequent clinical complication in patients with liver disease, heart failure and cancer. Fluid overload is a well-recognized problem in these growing diseases, causing severe problems for the large number of patients for whom current medicines are no longer effective. These patients can have up to 15 liters of extra fluid in their bodies, causing major medical issues including increased mortality, repeated hospitalizations, severe pain, difficult breathing and restricted mobility that severely impacts daily life. alfapump® and DSR® are Sequana Medical’s proprietary approaches that work with the body to remove this excess fluid, delivering major clinical and quality of life benefits for patients and reducing costs for healthcare systems. Sequana Medical is listed on Euronext Brussels (Ticker: SEQUA.BR) and headquartered in Ghent, Belgium. For further information, please visit www.sequanamedical.com.

ABCDx is revolutionising stroke management with the first mobile brain diagnostic platform that turns smartphones into medical devices. We equip healthcare providers with accessible tools to accurately diagnose stroke patients at point-of-care – and within only a few minutes. By pioneering the ability to decode chemical messages of the brain (brain biomarkers), we developed a clinically validated method to detect brain injury using just a single drop of blood from a finger prick. Interested to learn more or be part of the first mobile brain diagnostic platform? Our team would love to hear from you: https://www.abcdx.es/contact

The Haag-Streit Group, headquartered in Koeniz near Bern, is an internationally operating Swiss medical device company in the field of eye care. The group develops, manufactures and globally distributes cutting-edge solutions and medical devices including slit lamps, tonometers, chairs and stands for the refractive workplace, as well as biometers, perimeters, surgical microscopes and further accessories. The Haag-Streit Group also offers virtual reality-based solutions and simulators for medical education. For more than 160 years, Haag-Streit has been working closely with well-respected scientists and physicians worldwide. According to the principle:” Look closer, see further”, we work with attention to detail to develop and produce innovative and progressive comprehensive solutions of highest quality for eye care specialists.

Sensimed SA, a Swiss company, has developed a unique technology platform on non-invasive soft contact lens-based solution. The first application, the SENSIMED Triggerfish®, provides an automated recording of continuous ocular dimensional change over 24 hours with the aim of revolutionizing glaucoma management enhancing personalization of patient care. The SENSIMED Triggerfish® received the CE mark in 2010 and was approved by the U.S. Food and Drug Administration (FDA) in 2016. Since 2018 the device is registered in Japan at the Pharmaceuticals and Medical Devices Agency (PMDA). Other non-invasive on-eye sensing applications are in development to provide clinically pertinent data with the same continuous monitoring approach. The Company is furthermore focused on expanding the knowledge of how this individual data can best be used in the clinical setting to deliver customized treatment. The data, analysed and modeled on an ongoing basis, is processed in an attempt to identify pathological patterns that can be used to differentiate indication, personalize treatment and assess efficacy of treatment. The Company is directly positioned at the convergence between devices, treatment and information. Sensimed believes that with this global knowledge-based approach it will be possible to provide valuable insights that allow ophthalmologists to better understand and treat glaucoma. Sensimed became a subsidiary of SEED CO., Ltd after the acquisition of a majority participation end of 2019.

Dementia is a major problem in our aging societies costing nearly a trillion USD worldwide per year. Treatments are on the horizon, but an affordable and widely available diagnostic technique is still missing. Positrigo’s brain positron emission tomography system offers functional brain imaging to everyone at a fraction of today’s cost.

Auzen is revolutionizing access to hearing care by offering an unprecedented premium service: online access to a wide variety of state-of-the-art hearing aids, at a fair price.

We make you smile. At bestsmile, we're not just about orthodontic treatments; we're all about bringing confidence through radiant smiles. bestsmile is the leading Swiss orthodontics company with over 20 practices all over Switzerland, an own production site where everything is custom-made and over 90 dentists and orthodontists specialized in Aligner treatments for teens and adults and smile transformations with Veneers. 🔹 swiss made: we combine local expertise with global standards. All bestsmile products are custom-made in our own production site in Winterthur. 🔹 State-of-the-art technology: Utilizing advanced 3D printing technology, we provide custom-made and efficient orthodontic solutions. 🔹Dental Expertise: Our team of dental and orthodontic experts ensures a personalized journey towards your best smile. From discreet tooth corrections with clear Aligners for teens and adults to the perfect Hollywood smile with our ultra-thin Veneers, we cater to a diverse range of dental needs.

COLTENE is an internationally active developer, manufacturer and seller of dental consumables and small equipment in the areas of Infection Control, Dental Preservation and Efficient Treatment. COLTENE has state-of-the-art production facilities in the USA, Canada, Germany, France and Switzerland as well as own distribution organizations in all major markets including Europe, North and Latin America, Japan, China and India. Dentists and dental labs all around the globe trust COLTENE’s high-quality products. The registered shares of COLTENE Holding AG (CLTN) are listed on SIX Swiss Exchange.

The CYBATHLON is a competition for people with disabilities, who, supported by the latest assistive technologies in various disciplines, compete against each other and solve everyday tasks. Founded at ETH Zurich in 2014 we are driven by the following goals - Promotion of research, development and implementation of assistive technologies for people with disabilities - Building a common platform for technology developers, people with disabilities and the general public - Promoting a lively exchange between technology developers, people with disabilities and the general public - Informing the public about the possibilities and limitations of current assistance systems - Encouraging the discourse on inclusion and equality of people with disabilities in everyday life The CYBATHLON is a project of ETH Zurich.

Precipart is a global company engaged in the engineering, design and manufacture of high precision custom solutions. We provide precision mechanical components, assemblies, gears and motion control systems to the most recognized names in the medical, aerospace and industrial sectors. With offices in Switzerland, the U.S., and U.K. Precipart’s team members are dedicated to engineering possible. It is the vision of Precipart to enhance the lives of those who interact with us and our products. Whether we are providing products for patients or passengers, we are acutely aware that we play a critical role in things bigger than ourselves, and therefore we take responsibility for the quality and precision of our contribution.

Biolux Medical is biotechnology company that specializes in photomodulation.

Aesyra SA is a spin-off of EPFL created in November 2017 in close collaboration with medical experts from the Clinique Universitaire de Médecine Dentaire de Genève (CUMD). Aesyra’s mission is to develop, manufacture and commercialize a medical device able to accurately monitor the jaw activity of the patient during sleep and provide an active bio-feedback to reduce teeth grinding without waking-up the patient.

Loop medical is developing a painless blood collection technology compatible with existing laboratory infrastructure.

Lumendo, founded in 2018 and ISO 13485 certified, aims to disrupt the endodontic device market in the US and EU. Our mission is to develop the most advanced solution for this very challenging dental procedure with a disruptive cleaning technology and a novel, light-activated filler, thus helping people to keep their natural teeth longer.

At Neurosoft Bioelectronics, we strive at improving the care of patients who suffer from neurological disorders by developing soft implantable electrodes to interface with the nervous system. We have established a unique technology that allows to manufacture extremely compliant neural interfaces that can achieve long-term bio-integration in the body. These devices will improve therapeutic outcomes in patients as well as open up new applications for neural interfaces that were so far impossible.

Sleepiz AG (Ltd.) is a Zürich based startup with a mission to provide patient-centric disease management through seamless integration of contactless monitoring into people’s homes. Sleepiz leverages the power of sleep insights with a device that is simply placed next to the bed. The device operates in a non-contact fashion and measures movements originating from heart contractions and breathing patterns, as well as body motions with medical grade accuracy. While currently focusing on respiratory illnesses, Sleepiz aims to improve people’s lives by creating the future of healthcare. By making use of wireless millimeter wave technology, sensor fusion and artificial intelligence, in the future Sleepiz will not only be able to diagnose sleep disorders but also perform long-term monitoring. Thereby, the progression of chronic diseases will be monitored to allow faster intervention and better treatment. The company collaborates closely with leading clinics in Switzerland and Europe. Headquartered in Zürich, Switzerland, Sleepiz AG also has its own subsidiary in Pune, India. Within 3 years, the ETH spin-off has grown to a team of more than 40 people including PhDs in engineering, data modelling and signal processing, as well as business and healthcare professionals. Sleepiz is touching lives without touching.

When Madame Valérie Taupin created TEOXANE Laboratories in Geneva in 2003, her vision was crystal clear: to satisfy the ever demanding aesthetic market with high performance, avant-garde products based on rigorous scientific research. Today our focus remains unchanged. We are dedicated to designing and manufacturing hyaluronic acid dermal fillers and skincare products, applying industry-leading expertise and high-quality standards. Building on a firm commitment to innovation and patient satisfaction, we have strengthened our presence. In 2023, TEOXANE has over 10 subsidiaries and is present in more than 95 countries worldwide. TEOXANE is now confirmed as a major player in aesthetic medicine and skincare, offering effective solutions to practitioners worldwide, helping women and men who want to look and feel their best at all times and help them maintain their beauty in the future. Our core values of Innovation, Culture of Excellence and Independence continue to set us apart and guide our ambitions.

Netsensing aims to be a medical device legal manufacturer specialised in sleep apnea detection.

Die Procamed AG ist Schweizer Marktführer, wenn es um lebensrettende Geräte und Ausrüstungen geht. Seit über 27 Jahren sind wir der kompetente Partner für medizinaltechnische Lösungen in Rettungsdiensten, Kliniken, im Militär und auch für Laien. Die Defibrillatoren von ZOLL Medical sind für Profis und Laien geeignet. Der plötzliche Herz-Kreislaufstillstand ist einer der häufigsten Todesursachen in der Schweiz. Deshalb ist es wichtig, dass AEDs (Automatische Externe Defibrillatoren) an verschiedenen öffentlichen Standorten zu finden sind. Sie sind einfach in der Bedienung und leiten zu einer qualitativ hochwertigen Herzdruckmassage an. Des Weiteren gehörten Defibrillatoren/Monitore für Profis, Automatische CPR Geräte wie AutoPulse sowie verschiedene Softwarelösungen zur Produktpalette. Aber auch leistungsstarke, tragbare und überall einsetzbare Beatmungsgeräte für den Notfall-, Spital- oder Militäreinsatz bieten wir unseren Kunden an. Die Patientenmonitore von Mindray erweitern das Sortiment von Procamed ideal. Die Monitore eignen sich für den stationären wie auch für den ambulanten Einsatz. Sie sind einfach in der Handhabung und verfügen über die wichtigsten Überwachungsparameter. Auch die Notfallprodukte wie NIO (Neues Intraossäres Infusionssystem), Emergency Bandages, Wärmedecken und Verbrennungsbehandlung erfüllen die höchsten Ansprüche unserer Kunden.

Medizinische Exzellenz in Bewegung: Hospimed ist Ihr Schweizer Pionier in der Medizintechnik mit über 35 Jahren Erfahrung. Unser umfassendes Know-how ermöglicht es uns, Ihnen erstklassige Produkte und innovative Lösungen anzubieten. In Sachen Logistik setzen wir auf ausgefeilte Technik, um Ihnen eine der schnellsten Lieferzeiten in unserer Branche zu garantieren. Unsere engagierten Techniker stehen Ihnen jederzeit für Service- und Supportanfragen zur Verfügung, denn Ihre Zufriedenheit hat für uns oberste Priorität. Kein Wunder, dass einige der renommiertesten Ärzte und Kliniken auf die bewährte Expertise von Hospimed vertrauen. Entdecken Sie die Fusion von Schweizer Präzision und medizinischer Exzellenz – wir sind stolz darauf, Ihren hohen Standards gerecht zu werden.

Gegründet vom Keramikpionier und Implantologen Dr. Karl Ulrich Volz bietet Swiss Dental Solutions (SDS) ein umfassendes Behandlungskonzept für biologisch-immunologische Dental-Lösungen. Das Schweizer Unternehmen steht für einzigartige Keramik-Kompetenz, langjährige Expertise und überragende Behandlungserfolge mit Fokus auf Ästhetik, Gesundheit und Langlebigkeit.

1MED, is a leading MedTech industry-specialized solutions provider, offering global end-to-end development expertise within the medical device, novel technology and combination products fields. Founded in 2014, with headquarter in Agno, Switzerland, and employing 100+ professionals delivering operational support across the globe, 1MED's mission is to support all the MedTech organizations in facing the complexity associated with the development of innovative medical devices in compliance with MDR and FDA regulation. Such expertise includes the entire technology life cycle, from research and development, through commercialization, including advanced preclinical testing, quality management systems implementations, regulatory advice, clinical trials management and post marketing support across the medical device development continuum with a cross-functional approach which led to win the certification and certification maintenance of more than 500 different medical devices in the last few years. 1MED’s core clientele provides services to a wide range of organizations in the healthcare industry, including start-ups to the world's leading healthcare organizations, as well as global manufacturers and individuals. Our therapeutic expertise consists of all arenas of medical devices, with a concentrated focus on cardiovascular, orthopedic, ophthalmology, dental, dermatology, wound care, gastrointestinal, urology, surgical instruments, drug delivery systems, in vitro diagnostics and imaging/software/AI based medical devices. 1MED not only offers a broad range of internal competences, our clients in fact can trust on a preferred partners network and consolidated relationships with European Notified Bodies and Competent Authorities. There is much more to know about us! Please visit https://www.1med.ch/ to learn about the solutions we can offer or e-mail us: info@1med.ch

QUMEA® is the most advanced and comprehensive system for fall prevention and mobility monitoring in care institutions. Using a one-of-a-kind sensor and intelligent yet easy-to-use software, QUMEA continuously monitors activity and mobility of every patient and automatically calls for help, depending on the individual needs of each patient. This prevents falls, makes therapy success measurable, improves the patient outcome and noticeably relieves the burden on care. All this while fully respecting the privacy of everyone involved.

Through advancing research, observing natural behavior, and listening to our customers, Medela turns science into care while nurturing health for generations. Medela supports millions of moms, babies, patients, and healthcare professionals in more than 100 countries all over the world. As the healthcare choice for more than 6 million hospitals and homes across the globe, Medela provides the leading research-based breast milk feeding and baby products, healthcare solutions for hospitals, and clinical education. A family-owned company, Medela has 20 subsidiaries in Europe, the Americas, Asia and Australia, three production and warehouse facilities in Switzerland, the U.S and China and a worldwide distribution network in over 100 countries. With more than 1,500 employees, Medela is dedicated to developing breakthrough innovations that build better health outcomes and improve the lives of moms, babies and patients. Founded in 1961 by Olle Larsson, his son Michael Larsson serves as Chairman of the Board of Directors since 2001. Thomas Golücke is the CEO of the company since 2024. Medela is committed to providing equal employment opportunity (EEO) to all persons regardless of race, religion, color, national origin, ancestry, citizenship, sex, protected veteran status, age, physical or mental disability, medical condition, HIV/AIDS status, marital or domestic partner status, sexual orientation, gender identity, or any other characteristic protected by federal, state, or local law or ordinance.

Biotech Healthcare Group, founded in 1999, manufactures and supplies a range of products in Ophthalmology, Dermatology, Orthopaedics & Urology verticals. We are one of the leading manufacturers and suppliers of intraocular lenses, ophthalmic solutions and diagnostic range of equipment for eye care industry with production capacity of over 2.4 million lenses per year. With our sales and marketing Headquarters in Luzern, Switzerland, we have established research & development centers with state-of-the-art manufacturing facilities in Roscommon, Ireland and Ahmedabad, India. Today, our products reach in more than 90 countries including Europe, South America, Middle East, South-East Asia and SAARC Nations. Our people at Biotech come from divergent backgrounds and experiences. Our common goal, urge for innovation, passion for developing high quality products & commitment towards customer service helps us to move every step closer towards serving people for a better life.

At flowbone, we aim for a world where the elderly can enjoy a high level of independence and quality of life, free from the devastating impact of fragility fractures.

GMI is a Swiss company that designs and manufactures X-ray equipment. Our team of experienced professionals is dedicated to providing state-of-the-art products at competitive prices. Our research and development department is always on the lookout for new technologies, and we collaborate closely with leading research institutions to develop innovative and efficient solutions. GMI is committed to meeting the highest quality standards and business practices. Our goal is to provide our customers with the best possible experience.